Sep 01, 2021/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Infertility Services Market.
It was estimated prior to this unanticipated outbreak that the Infertility Services Market was expected to grow at a CAGR of 8.5% during the forecast period. However, the gradual slowing down of industries will undoubtedly impose limits on the previously estimated growth rate.
The declining fertility rate is one of the key drivers of the infertility services market growth. Also, the growing number of fertility clinics across the globe, rising public-private investments, funds, and grants; and technological advancements are other factors that augment the infertility services industry. Moreover, the rise in the prevalence of delayed pregnancies and growth in infertility rates further boost the market expansion. However, the expensive procedural cost of ART procedures is likely to hinder the industry growth.
By patient type, the global infertility services market has been bifurcated into females and males. Under these, the female segment held the highest market share in 2020 and is projected to grow at a healthy CAGR during the assessment period. Infertility is one of the most common medical conditions diagnosed among women. Availability of a broad variety of treatment options, rising awareness about infertility treatments, growing female infertility rates, and the increasing number of fertility centers facilitate the growth of this segment.
By region, the North America market held the largest market share in 2020 and is likely to register a steady CAGR in the coming years. This is mainly attributed to the increasing adoption rate for IVF treatment, well-established healthcare facilities, late pregnancies, and decreasing fertility rates. According to the National Center for Health Statistics, the birth rate in the US in 2015 was around 12.5 per 1,000, whereas the fertility rate was 62.5 births per 1,000 women. Thus, poor infertility rates, drives the regional infertility services growth.
Key Players:
Key players operating in the global Infertility Services market are-
· Cook Group Incorporated (The U.S),
· Esco Micro Pte. Ltd. (Singapore),
· Genea Limited (Australia),
· Hamilton Throne, Ltd. (The U.S),
· Ihmedical A/S (Denmark),
· Irvine Scientific (The U.S),
· IVFTech Aps (Denmark),
· Kitazato Corporation (Japan),
· Medgyn Products, Inc. (The U.S), and
· Rocket Medical PLC (UK).
Features of the Report
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.
The Infertility Services analysis report discusses the following heads in great detail:
· Market structure: Overview, industry life cycle analysis, supply chain analysis
· COVID-19 Impact Assessment
· Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
· Market trend and forecast analysis
· Market segment trend and forecast
· Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
· Attractive market segments and associated growth opportunities
· Emerging trends
· Strategic growth opportunities for the existing and new players
· Key success factors
Know more about Stratview Research:
Stratview Research is a global market research company and is known to offer custom research reports in varied fields such as aerospace & Defense, Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. Our team makes sure to have deep research about the topics so that the most useful insights can be delivered to the professionals.
Need a detailed report? Get in touch with us:
Stratview Research
E-mail: sales@stratviewresearch.com
Direct: +1-313-307-4176
Write a comment